Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion

While minimally invasive follicular thyroid cancer (miFTC) generally has low risk of recurrence or death, encapsulated angioinvasive (eaFTC) or widely invasive (wiFTC) histological subtypes display significantly worse prognosis. Drivers of invasion are incompletely understood. Therefore, tissue samp...

Full description

Saved in:
Bibliographic Details
Published in:Endocrine pathology 2020-12, Vol.31 (4), p.367-376
Main Authors: Nicolson, Norman G., Paulsson, Johan O., Juhlin, C. Christofer, Carling, Tobias, Korah, Reju
Format: Article
Language:English
Subjects:
Acetylation
Drug development
Endocrinology
Gene expression
Histones
Immunohistochemistry
Immunomodulation
Medicin och hälsovetenskap
Medicine
Medicine & Public Health
Oncology
Pathology
Sp1 protein
Thyroid cancer
Transcription factors
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c605t-2f219fcc75a860307d6b535e62e9f81ea46761bc48f710ce30dc18ed12c210773
cites cdi_FETCH-LOGICAL-c605t-2f219fcc75a860307d6b535e62e9f81ea46761bc48f710ce30dc18ed12c210773
container_end_page 376
container_issue 4
container_start_page 367
container_title Endocrine pathology
container_volume 31
creator Nicolson, Norman G.
Paulsson, Johan O.
Juhlin, C. Christofer
Carling, Tobias
Korah, Reju
description While minimally invasive follicular thyroid cancer (miFTC) generally has low risk of recurrence or death, encapsulated angioinvasive (eaFTC) or widely invasive (wiFTC) histological subtypes display significantly worse prognosis. Drivers of invasion are incompletely understood. Therefore, tissue samples including miFTC, eaFTC, and wiFTC tumors, as well as histologically normal thyroid adjacent to benign follicular adenomas, were selected from a cohort ( n  = 21) of thyroid tumor patients, and the gene expression of selected transcription factors was characterized with quantitative PCR. Invasion-relevant spatial expression patterns of selected transcription factors were subsequently characterized with immunohistochemistry. E2F1 was over-expressed in all 3 subtypes ( p
doi_str_mv 10.1007/s12022-020-09651-0
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_467321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2451849484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c605t-2f219fcc75a860307d6b535e62e9f81ea46761bc48f710ce30dc18ed12c210773</originalsourceid><addsrcrecordid>eNp9kktv1DAUhSMEog_4A6wssWETuH7ETjZIaNShIxWBxLC2PM7N1MVjBzspmn-P2xmoigQrX9nfObaOT1W9ovCWAqh3mTJgrAYGNXSyoTU8qU5p03Q1QKeelhmErHmn5El1lvMNAOUA7Hl1wjlIzhp6Wo3rZEK2yY2Ti4EsjZ1iIl9SHJx3YUtWPYbJDQ4z-TqayRnv9-QSJ0xxiyHOmXzC3pkiyiQOZBm9d3b2JpH19T5F15OFCRYTWYVbk8sVL6png_EZXx7X8-rb8mK9uKyvPn9cLT5c1VZCM9VsYLQbrFWNaSVwUL3cNLxBybAbWopGSCXpxop2UBQscugtbbGnzDIKSvHzqj745p84zhs9Jrczaa-jcfq49b1MqIsRZ7Tw3T_5McX-QfRbSIXoSqTAi_b9QVuAHfa2RJaMf2zx6CS4a72Nt1pJKVl7Z_DmaJDijxnzpHcuW_TeBCwZayYa2opOtKKgr_9Cb-KcQomyUIq2IMp_F4odKJtizgmHP4-hoO_Kow_l0aU8-r48GoqIHyMocNhierD-j-oXz8DJGQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471804976</pqid></control><display><type>article</type><title>Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion</title><source>Springer Nature</source><creator>Nicolson, Norman G. ; Paulsson, Johan O. ; Juhlin, C. Christofer ; Carling, Tobias ; Korah, Reju</creator><creatorcontrib>Nicolson, Norman G. ; Paulsson, Johan O. ; Juhlin, C. Christofer ; Carling, Tobias ; Korah, Reju</creatorcontrib><description>While minimally invasive follicular thyroid cancer (miFTC) generally has low risk of recurrence or death, encapsulated angioinvasive (eaFTC) or widely invasive (wiFTC) histological subtypes display significantly worse prognosis. Drivers of invasion are incompletely understood. Therefore, tissue samples including miFTC, eaFTC, and wiFTC tumors, as well as histologically normal thyroid adjacent to benign follicular adenomas, were selected from a cohort ( n  = 21) of thyroid tumor patients, and the gene expression of selected transcription factors was characterized with quantitative PCR. Invasion-relevant spatial expression patterns of selected transcription factors were subsequently characterized with immunohistochemistry. E2F1 was over-expressed in all 3 subtypes ( p &lt;0.01). SP1 was differentially expressed in eaFTC and wiFTC compared with normal ( p =0.01 and 0.04, respectively). TCF7L2 was significantly upregulated in wiFTC specifically ( p &lt;0.05). While these findings were mRNA specific, immunohistochemistry of additional cancer-associated transcription factors revealed differential expression along the tumor invasive front relative to the central tumor, and histone acetylation modulators emerged as putative invasion markers. These findings may have significant implications for the interpretation of bulk gene expression analysis of thyroid tumor samples or for the development of targeted therapeutics for this rare but aggressive thyroid cancer variant.</description><identifier>ISSN: 1046-3976</identifier><identifier>ISSN: 1559-0097</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/s12022-020-09651-0</identifier><identifier>PMID: 33063251</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acetylation ; Drug development ; Endocrinology ; Gene expression ; Histones ; Immunohistochemistry ; Immunomodulation ; Medicin och hälsovetenskap ; Medicine ; Medicine &amp; Public Health ; Oncology ; Pathology ; Sp1 protein ; Thyroid cancer ; Transcription factors ; Tumors</subject><ispartof>Endocrine pathology, 2020-12, Vol.31 (4), p.367-376</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c605t-2f219fcc75a860307d6b535e62e9f81ea46761bc48f710ce30dc18ed12c210773</citedby><cites>FETCH-LOGICAL-c605t-2f219fcc75a860307d6b535e62e9f81ea46761bc48f710ce30dc18ed12c210773</cites><orcidid>0000-0002-5945-9081</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:144900103$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Nicolson, Norman G.</creatorcontrib><creatorcontrib>Paulsson, Johan O.</creatorcontrib><creatorcontrib>Juhlin, C. Christofer</creatorcontrib><creatorcontrib>Carling, Tobias</creatorcontrib><creatorcontrib>Korah, Reju</creatorcontrib><title>Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><description>While minimally invasive follicular thyroid cancer (miFTC) generally has low risk of recurrence or death, encapsulated angioinvasive (eaFTC) or widely invasive (wiFTC) histological subtypes display significantly worse prognosis. Drivers of invasion are incompletely understood. Therefore, tissue samples including miFTC, eaFTC, and wiFTC tumors, as well as histologically normal thyroid adjacent to benign follicular adenomas, were selected from a cohort ( n  = 21) of thyroid tumor patients, and the gene expression of selected transcription factors was characterized with quantitative PCR. Invasion-relevant spatial expression patterns of selected transcription factors were subsequently characterized with immunohistochemistry. E2F1 was over-expressed in all 3 subtypes ( p &lt;0.01). SP1 was differentially expressed in eaFTC and wiFTC compared with normal ( p =0.01 and 0.04, respectively). TCF7L2 was significantly upregulated in wiFTC specifically ( p &lt;0.05). While these findings were mRNA specific, immunohistochemistry of additional cancer-associated transcription factors revealed differential expression along the tumor invasive front relative to the central tumor, and histone acetylation modulators emerged as putative invasion markers. These findings may have significant implications for the interpretation of bulk gene expression analysis of thyroid tumor samples or for the development of targeted therapeutics for this rare but aggressive thyroid cancer variant.</description><subject>Acetylation</subject><subject>Drug development</subject><subject>Endocrinology</subject><subject>Gene expression</subject><subject>Histones</subject><subject>Immunohistochemistry</subject><subject>Immunomodulation</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Sp1 protein</subject><subject>Thyroid cancer</subject><subject>Transcription factors</subject><subject>Tumors</subject><issn>1046-3976</issn><issn>1559-0097</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kktv1DAUhSMEog_4A6wssWETuH7ETjZIaNShIxWBxLC2PM7N1MVjBzspmn-P2xmoigQrX9nfObaOT1W9ovCWAqh3mTJgrAYGNXSyoTU8qU5p03Q1QKeelhmErHmn5El1lvMNAOUA7Hl1wjlIzhp6Wo3rZEK2yY2Ti4EsjZ1iIl9SHJx3YUtWPYbJDQ4z-TqayRnv9-QSJ0xxiyHOmXzC3pkiyiQOZBm9d3b2JpH19T5F15OFCRYTWYVbk8sVL6png_EZXx7X8-rb8mK9uKyvPn9cLT5c1VZCM9VsYLQbrFWNaSVwUL3cNLxBybAbWopGSCXpxop2UBQscugtbbGnzDIKSvHzqj745p84zhs9Jrczaa-jcfq49b1MqIsRZ7Tw3T_5McX-QfRbSIXoSqTAi_b9QVuAHfa2RJaMf2zx6CS4a72Nt1pJKVl7Z_DmaJDijxnzpHcuW_TeBCwZayYa2opOtKKgr_9Cb-KcQomyUIq2IMp_F4odKJtizgmHP4-hoO_Kow_l0aU8-r48GoqIHyMocNhierD-j-oXz8DJGQ</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Nicolson, Norman G.</creator><creator>Paulsson, Johan O.</creator><creator>Juhlin, C. Christofer</creator><creator>Carling, Tobias</creator><creator>Korah, Reju</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-5945-9081</orcidid></search><sort><creationdate>20201201</creationdate><title>Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion</title><author>Nicolson, Norman G. ; Paulsson, Johan O. ; Juhlin, C. Christofer ; Carling, Tobias ; Korah, Reju</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c605t-2f219fcc75a860307d6b535e62e9f81ea46761bc48f710ce30dc18ed12c210773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acetylation</topic><topic>Drug development</topic><topic>Endocrinology</topic><topic>Gene expression</topic><topic>Histones</topic><topic>Immunohistochemistry</topic><topic>Immunomodulation</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Sp1 protein</topic><topic>Thyroid cancer</topic><topic>Transcription factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nicolson, Norman G.</creatorcontrib><creatorcontrib>Paulsson, Johan O.</creatorcontrib><creatorcontrib>Juhlin, C. Christofer</creatorcontrib><creatorcontrib>Carling, Tobias</creatorcontrib><creatorcontrib>Korah, Reju</creatorcontrib><collection>SpringerOpen</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nicolson, Norman G.</au><au>Paulsson, Johan O.</au><au>Juhlin, C. Christofer</au><au>Carling, Tobias</au><au>Korah, Reju</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion</atitle><jtitle>Endocrine pathology</jtitle><stitle>Endocr Pathol</stitle><date>2020-12-01</date><risdate>2020</risdate><volume>31</volume><issue>4</issue><spage>367</spage><epage>376</epage><pages>367-376</pages><issn>1046-3976</issn><issn>1559-0097</issn><eissn>1559-0097</eissn><abstract>While minimally invasive follicular thyroid cancer (miFTC) generally has low risk of recurrence or death, encapsulated angioinvasive (eaFTC) or widely invasive (wiFTC) histological subtypes display significantly worse prognosis. Drivers of invasion are incompletely understood. Therefore, tissue samples including miFTC, eaFTC, and wiFTC tumors, as well as histologically normal thyroid adjacent to benign follicular adenomas, were selected from a cohort ( n  = 21) of thyroid tumor patients, and the gene expression of selected transcription factors was characterized with quantitative PCR. Invasion-relevant spatial expression patterns of selected transcription factors were subsequently characterized with immunohistochemistry. E2F1 was over-expressed in all 3 subtypes ( p &lt;0.01). SP1 was differentially expressed in eaFTC and wiFTC compared with normal ( p =0.01 and 0.04, respectively). TCF7L2 was significantly upregulated in wiFTC specifically ( p &lt;0.05). While these findings were mRNA specific, immunohistochemistry of additional cancer-associated transcription factors revealed differential expression along the tumor invasive front relative to the central tumor, and histone acetylation modulators emerged as putative invasion markers. These findings may have significant implications for the interpretation of bulk gene expression analysis of thyroid tumor samples or for the development of targeted therapeutics for this rare but aggressive thyroid cancer variant.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33063251</pmid><doi>10.1007/s12022-020-09651-0</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-5945-9081</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1046-3976
ispartof Endocrine pathology, 2020-12, Vol.31 (4), p.367-376
issn 1046-3976
1559-0097
1559-0097
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_467321
source Springer Nature
subjects Acetylation
Drug development
Endocrinology
Gene expression
Histones
Immunohistochemistry
Immunomodulation
Medicin och hälsovetenskap
Medicine
Medicine & Public Health
Oncology
Pathology
Sp1 protein
Thyroid cancer
Transcription factors
Tumors
title Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A41%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcription%20Factor%20Profiling%20Identifies%20Spatially%20Heterogenous%20Mediators%20of%20Follicular%20Thyroid%20Cancer%20Invasion&rft.jtitle=Endocrine%20pathology&rft.au=Nicolson,%20Norman%20G.&rft.date=2020-12-01&rft.volume=31&rft.issue=4&rft.spage=367&rft.epage=376&rft.pages=367-376&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/s12022-020-09651-0&rft_dat=%3Cproquest_swepu%3E2451849484%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c605t-2f219fcc75a860307d6b535e62e9f81ea46761bc48f710ce30dc18ed12c210773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2471804976&rft_id=info:pmid/33063251&rfr_iscdi=true